.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020734

« Back to Dashboard
NDA 020734 describes CLINIMIX 5/35 SULFITE FREE IN DEXTROSE 35% IN PLASTIC CONTAINER, which is a drug marketed by Baxter Hlthcare and is included in one NDA. It is available from one supplier. Additional details are available on the CLINIMIX 5/35 SULFITE FREE IN DEXTROSE 35% IN PLASTIC CONTAINER profile page.

The generic ingredient in CLINIMIX 5/35 SULFITE FREE IN DEXTROSE 35% IN PLASTIC CONTAINER is amino acids; dextrose. There are three hundred and thirty drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the amino acids; dextrose profile page.

Summary for NDA: 020734

Pharmacology for NDA: 020734

Ingredient-typeAmino Acids

Suppliers and Packaging for NDA: 020734

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CLINIMIX 2.75/10 SULFITE FREE IN DEXTROSE 10% IN PLASTIC CONTAINER
amino acids; dextrose
INJECTABLE;INJECTION 020734 NDA Baxter Healthcare Corporation 0338-1083 0338-1083-04 2000 mL in 1 BAG (0338-1083-04)
CLINIMIX 2.75/10 SULFITE FREE IN DEXTROSE 10% IN PLASTIC CONTAINER
amino acids; dextrose
INJECTABLE;INJECTION 020734 NDA Baxter Healthcare Corporation 0338-1089 0338-1089-04 2000 mL in 1 BAG (0338-1089-04)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength2.75%;5GM/100ML
Approval Date:Sep 29, 1997TE:RLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength2.75%;10GM/100ML
Approval Date:Sep 29, 1997TE:RLD:No

Summary for product number 005

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength2.75%;25GM/100ML
Approval Date:Sep 29, 1997TE:RLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc